E. Nestler, Is there a common molecular pathway for addiction?, Nature Neuroscience, vol.12, issue.11, pp.1445-1449, 2005.
DOI : 10.1016/j.neuropharm.2004.06.025

K. Alex and E. Pehek, Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission, Pharmacology & Therapeutics, vol.113, issue.2, pp.296-320, 2007.
DOI : 10.1016/j.pharmthera.2006.08.004

P. De-deurwaerdere, L. Stinus, and U. Spampinato, Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors, J Neurosci, vol.18, pp.6528-6538, 1998.

M. Bankson and K. Cunningham, 4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonindopamine interactions, J Pharmacol Exp Ther, vol.3, issue.297, pp.846-852, 2001.

M. Bankson and B. Yamamoto, Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release, Journal of Neurochemistry, vol.91, issue.4, pp.852-859, 2004.
DOI : 10.1111/j.1471-4159.2004.02763.x

J. Kehne, H. Ketteler, T. Mccloskey, C. Sullivan, and M. Dudley, Effects of the Selective 5-HT2A Receptor Antagonist MDL 100,907 on MDMA-Induced Locomotor Stimulation in Rats, Neuropsychopharmacology, vol.15, issue.2, pp.116-124, 1996.
DOI : 10.1016/0893-133X(95)00160-F

K. Scearce-levie, S. Viswanathan, and R. Hen, Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT 1B receptor, Psychopharmacology, vol.141, issue.2, pp.154-161, 1999.
DOI : 10.1007/s002130050819

K. Ball and G. Rebec, Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats, Psychopharmacology, vol.180, issue.4, pp.676-687, 2005.
DOI : 10.1007/s00213-005-0038-z

G. Rudnick and S. Wall, The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release., Proceedings of the National Academy of Sciences, vol.89, issue.5, pp.1817-1821, 1992.
DOI : 10.1073/pnas.89.5.1817

G. Gudelsky and J. Nash, Carrier-Mediated Release of Serotonin by 3,4-Methylenedioxymethamphetamine: Implications for Serotonin-Dopamine Interactions, Journal of Neurochemistry, vol.66, issue.1, pp.243-249, 1996.
DOI : 10.1046/j.1471-4159.1996.66010243.x

S. Koch and M. Galloway, MDMA induced dopamine release in vivo: role of endogenous serotonin, Journal of Neural Transmission, vol.148, issue.2-3, pp.135-146, 1997.
DOI : 10.1007/BF01273176

J. Nash and J. Brodkin, Microdialysis studies on 3,4-methylenedioxymetham- phetamine-induced dopamine release: effect of dopamine uptake inhibitors, J Pharmacol Exp Ther, vol.259, pp.820-825, 1991.

M. Liechti, C. Baumann, A. Gamma, and F. Vollenweider, Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, ???Ecstasy???) are Attenuated by the Serotonin Uptake Inhibitor Citalopram, Neuropsychopharmacology, vol.22, issue.5, pp.513-521, 2000.
DOI : 10.1016/S0893-133X(99)00148-7

P. Bonaventure, H. Guo, B. Tian, X. Liu, and A. Bittner, Nuclei and subnuclei gene expression profiling in mammalian brain, Brain Research, vol.943, issue.1, pp.38-47, 2002.
DOI : 10.1016/S0006-8993(02)02504-0

K. Schmuck, C. Ullmer, H. Kalkman, A. Probst, and H. Lubbert, Receptors: An Early Step in the Generation of Migraine Headache?, European Journal of Neuroscience, vol.ii, issue.Suppl. 2, pp.959-967, 1996.
DOI : 10.1111/j.1460-9568.1996.tb01583.x

D. Choi and L. Maroteaux, Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain, FEBS Letters, vol.54, issue.1-2, pp.45-51, 1996.
DOI : 10.1016/0014-5793(96)00695-3

M. Duxon, T. Flanigan, A. Reavley, G. Baxter, and T. Blackburn, Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system, Neuroscience, vol.76, issue.2, pp.323-329, 1997.
DOI : 10.1016/S0306-4522(96)00480-0

J. Launay, B. Schneider, S. Loric, D. Prada, M. Kellermann et al., Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells, The FASEB Journal, vol.20, issue.11, pp.1843-1854, 2006.
DOI : 10.1096/fj.06-5724com

S. Doly, E. Valjent, V. Setola, J. Callebert, and D. Herve, Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro, Journal of Neuroscience, vol.28, issue.11, pp.2933-2940, 2008.
DOI : 10.1523/JNEUROSCI.5723-07.2008
URL : https://hal.archives-ouvertes.fr/inserm-00484533

S. Gong, C. Zheng, M. Doughty, K. Losos, and N. Didkovsky, A gene expression atlas of the central nervous system based on bacterial artificial chromosomes, Nature, vol.425, issue.6961, pp.917-925, 2003.
DOI : 10.1038/nature02033

E. Valjent, J. Bertran-gonzalez, B. Aubier, P. Greengard, and D. Herve, Mechanisms of Locomotor Sensitization to Drugs of Abuse in a Two-Injection Protocol, Neuropsychopharmacology, vol.34, issue.2, 2009.
DOI : 10.1016/j.neuron.2008.05.028

T. Tzschentke, Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade, Addiction Biology, vol.21, issue.3-4, pp.227-462, 2007.
DOI : 10.1016/S0306-4522(99)00309-7

J. Bertran-gonzalez, C. Bosch, M. Maroteaux, M. Matamales, and D. Herve, Opposing Patterns of Signaling Activation in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons in Response to Cocaine and Haloperidol, Journal of Neuroscience, vol.28, issue.22, pp.5671-5685, 2008.
DOI : 10.1523/JNEUROSCI.1039-08.2008

D. Bonhaus, L. Flippin, R. Greenhouse, S. Jaime, and C. Rocha, receptor antagonist, British Journal of Pharmacology, vol.277, issue.5, pp.1075-1082, 1999.
DOI : 10.1038/sj.bjp.0702632

J. Stewart and A. Badiani, Tolerance and sensitization to the behavioral effects of drugs, Behavioural Pharmacology, vol.4, issue.4, pp.289-312, 1993.
DOI : 10.1097/00008877-199308000-00003

K. Berridge and T. Robinson, What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?, Brain Research Reviews, vol.28, issue.3, pp.309-369, 1998.
DOI : 10.1016/S0165-0173(98)00019-8

T. Robinson and K. Berridge, The neural basis of drug craving: An incentive-sensitization theory of addiction, Brain Research Reviews, vol.18, issue.3, pp.247-291, 1993.
DOI : 10.1016/0165-0173(93)90013-P

P. Vezina, Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs, Neuroscience & Biobehavioral Reviews, vol.27, issue.8, pp.827-839, 2004.
DOI : 10.1016/j.neubiorev.2003.11.001

D. Crespi, T. Mennini, and M. Gobbi, Carrier-dependent and Ca(2+)- dependent 5-HT and dopamine release induced by (+)-amphetamine, p.4, 1997.

J. Girault, E. Valjent, J. Caboche, and D. Herve, ERK2: a logical AND gate critical for drug-induced plasticity?, Current Opinion in Pharmacology, vol.7, issue.1, pp.77-85, 2007.
DOI : 10.1016/j.coph.2006.08.012
URL : https://hal.archives-ouvertes.fr/inserm-00128883

J. Salzmann, C. Marie-claire, L. Guen, S. Roques, B. Noble et al., Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice, British Journal of Pharmacology, vol.77, issue.5, pp.831-838, 2003.
DOI : 10.1038/sj.bjp.0705506
URL : https://hal.archives-ouvertes.fr/inserm-00171261

E. Valjent, J. Corvol, C. Pages, M. Besson, and R. Maldonado, Involvement of the extracellular signal-regulated kinase cascade for cocainerewarding properties, J Neurosci, vol.20, pp.8701-8709, 2000.

C. Cadoni, M. Solinas, A. Pisanu, G. Zernig, and E. Acquas, Effect of 3,4-methylendioxymethamphetamine (MDMA, ???ecstasy???) on dopamine transmission in the nucleus accumbens shell and core, Brain Research, vol.1055, issue.1-2, pp.143-148, 2005.
DOI : 10.1016/j.brainres.2005.07.002

Y. Kawaguchi, C. Wilson, S. Augood, and P. Emson, Striatal interneurones: chemical, physiological and morphological characterization, Trends in Neurosciences, vol.18, issue.12, pp.527-535, 1995.
DOI : 10.1016/0166-2236(95)98374-8

C. Gerfen, T. Engber, L. Mahan, Z. Susel, and T. Chase, D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, vol.250, issue.4986, pp.1429-1432, 1990.
DOI : 10.1126/science.2147780

D. Self, W. Barnhart, D. Lehman, and E. Nestler, Opposite Modulation of Cocaine-Seeking Behavior by D1- and D2-Like Dopamine Receptor Agonists, Science, vol.271, issue.5255, pp.1586-1589, 1996.
DOI : 10.1126/science.271.5255.1586

M. Ramos, B. Goni-allo, and N. Aguirre, Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats, Psychopharmacology, vol.69, issue.1-2, pp.100-110, 2004.
DOI : 10.1007/s00213-004-1937-0

N. Benturquia, C. Courtin, F. Noble, and C. Marie-claire, Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice, Brain Research, vol.1211, pp.1-5, 2008.
DOI : 10.1016/j.brainres.2008.03.016
URL : https://hal.archives-ouvertes.fr/inserm-00279098

E. Daniela, K. Brennan, D. Gittings, L. Hely, and S. Schenk, Effect of SCH 23390 on (??)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats, Pharmacology Biochemistry and Behavior, vol.77, issue.4, pp.745-750, 2004.
DOI : 10.1016/j.pbb.2004.01.008

E. Acquas, A. Pisanu, S. Spiga, A. Plumitallo, and G. Zernig, Differential effects of intravenous R,S-(???)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(?)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core, Journal of Neurochemistry, vol.22, issue.1, pp.121-132, 2007.
DOI : 10.1016/0014-2999(88)90564-X

M. Matamales, J. Bertran-gonzalez, L. Salomon, B. Degos, and J. Deniau, Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice, PLoS ONE, vol.22, issue.3, p.4770, 2009.
DOI : 10.1371/journal.pone.0004770.s002

L. Zhang, D. Lou, H. Jiao, D. Zhang, and X. Wang, Cocaine-Induced Intracellular Signaling and Gene Expression Are Oppositely Regulated by the Dopamine D1 and D3 Receptors, Journal of Neuroscience, vol.24, issue.13, pp.3344-3354, 2004.
DOI : 10.1523/JNEUROSCI.0060-04.2004

A. Stipanovich, E. Valjent, M. Matamales, A. Nishi, and J. Ahn, A phosphatase cascade by which rewarding stimuli control nucleosomal response, Nature, vol.20, issue.7197, pp.879-884, 2008.
DOI : 10.1038/nature06994
URL : https://hal.archives-ouvertes.fr/cea-00944345

B. Hope, H. Nye, M. Kelz, D. Self, and M. Iadarola, Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments, Neuron, vol.13, issue.5, pp.1235-1244, 1994.
DOI : 10.1016/0896-6273(94)90061-2

C. Callaway, L. Wing, and M. Geyer, Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats, J Pharmacol Exp Ther, vol.254, pp.456-464, 1990.

M. Federici, L. Sebastianelli, S. Natoli, G. Bernardi, and N. Mercuri, Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/???) -3,4-Methylenedioxymethamphetamine (MDMA??????Ecstasy???), Biological Psychiatry, vol.62, issue.6, pp.680-686, 2007.
DOI : 10.1016/j.biopsych.2006.11.019

M. Baumann, M. Ayestas, C. Dersch, A. Brockington, and K. Rice, Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications, Synapse, vol.42, issue.2, pp.102-113, 2000.
DOI : 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#

U. Berger, X. Gu, and E. Azmitia, The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine, European Journal of Pharmacology, vol.215, issue.2-3, pp.153-160, 1992.
DOI : 10.1016/0014-2999(92)90023-W

R. Rothman, B. Blough, and M. Baumann, Dual Dopamine/Serotonin Releasers as Potential Medications for Stimulant and Alcohol Addictions, AAPS J, vol.9, pp.1-10, 2007.
DOI : 10.1007/978-0-387-76678-2_19

V. Setola, S. Hufeisen, K. Grande-allen, I. Vesely, and R. Glennon, Ecstasy'') induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro, Mol Pharmacol, vol.3, issue.63, pp.4-1223, 2003.

A. Parrott, Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity, Psychopharmacology, vol.173, issue.3-4, pp.234-241, 2004.
DOI : 10.1007/s00213-003-1712-7

M. Baumann, X. Wang, and R. Rothman, 4-Methylenedioxymethamphe- tamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings, Psychopharmacology (Berl), vol.3, issue.189, pp.407-424, 2007.

L. Nelson, A. Erdman, L. Booze, D. Cobaugh, and P. Chyka, Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management, Clinical Toxicology, vol.36, issue.15, pp.315-332, 2007.
DOI : 10.1081/CLT-120037428

B. Slot, L. Bardin, L. Auclair, A. Depoortere, R. Newman-tancredi et al., Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice, Behavioural Pharmacology, vol.19, issue.2, pp.145-152, 2008.
DOI : 10.1097/FBP.0b013e3282f62cb2

H. Swainston and C. Perry, Aripiprazole, Drugs, vol.60, issue.2-3, pp.1715-1736, 2004.
DOI : 10.2165/00003495-200464150-00010

D. Wainscott, V. Lucaites, J. Kursar, M. Baez, and D. Nelson, Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences, J Pharmacol Exp Ther, vol.276, pp.720-727, 1996.

W. Blessing, B. Seaman, N. Pedersen, and Y. Ootsuka, Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats, J Neurosci, vol.23, pp.6385-6391, 2003.

K. Shioda, K. Nisijima, T. Yoshino, K. Kuboshima, and T. Iwamura, Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats, NeuroToxicology, vol.29, issue.6, pp.1030-1036, 2008.
DOI : 10.1016/j.neuro.2008.07.005